For Treatment of Infections caused by Multiple-resistant Gm +Ve organisms

Linezolid 600 mg

The Powerful Anti-Bacterial For Mixed Infections

The Voice of Safety & Efficacy In Bacterial Manifestations

  • Important in the treatment of life-threatening infections
  • Active against staphylococci, pneumococci and enterococci, including those resistant to penicillin and vancomycin
  • Highly effective against resistant gram+ve bacterias
  • Offers a treatment option for patients who are intolerant of vancomycin as well as other antibacterial agents
  • Drug of choice for MRSA and VRE infections
  • Excellent penetration into pulmonary, as well as skin & related structure tissues.
Prescribe In
  • AECB (Acute Exacerbations of Chronic bronchitis)
  • Vancomycin-Resistant Infections
  • Community-Acquired Pneumonia
  • Nosocomial Pneumonia
  • Skin & skin-structure Infections